对节点阴性非小细胞肺癌的外科免疫疗法-目前的证据和未来的方向
Muhammad H Shahzad1, Jonathan D Spicer1, Valerie W Rusch2
1Division of Thoracic Surgery, Department of Surgery, Montreal General Hospital, Montreal, Quebec, Canada; Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
The Annals of thoracic surgery
|April 15, 2024
概括
新辅助免疫疗法现在是高级肺癌的标准. 本综述探讨了其在早期,节点阴性肺癌患者的潜在用途,强调了机遇和挑战.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 肺癌研究研究 肺癌研究
背景情况:
- 新辅助免疫疗法已成为局部晚期肺癌的标准治疗方法.
- 目前的试验不足以代表早期 (I期和II期) 节点阴性肺癌患者.
- 前期切除,其次是有限的辅助疗法,是目前早期肺癌的标准.
研究的目的:
- 审查术后免疫疗法在节点阴性肺癌中的机会和争议.
- 讨论补充检查点封锁在选择的早期患者中的潜在作用.
- 突出生物标志物方法在患者选择中的重要性.
主要方法:
- 对局部晚期肺癌中新辅助化学免疫疗法的现有III期试验数据的审查.
- 对早期结节阴性肺癌中术前免疫疗法的新兴证据的分析.
- 讨论基于瘤免疫微环境的患者选择生物标志物策略.
主要成果:
- 新辅助化疗免疫疗法在局部发达的肺癌中显示出优于化疗的优势.
- 新出现的证据表明,检查点封锁在特定早期,节点阴性患者中的潜在益处.
- 生物标志物方法可以改善患者对免疫治疗的选择.
结论:
- 虽然新辅助免疫疗法已经推进了肺癌治疗,但早期结节阴性患者仍然是一个未满足的需求.
- 对于精心挑选的早期肺癌患者,对外科期免疫治疗和新生物标志物的进一步研究是有必要的.
- 仔细选择患者对于减轻安全问题和优化结果至关重要.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
724
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
相关概念视频
01:27Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
01:30Cancer Vaccines
360
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
360
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K